02:39 PM EDT, 05/08/2024 (MT Newswires) -- MaxCyte ( MXCT ) shares were up more than 20% in recent Wednesday trading after the company reported better-than-expected Q1 results in the previous day.

The company reported late Tuesday a Q1 loss of $0.09 per diluted share, compared with a loss of $0.11 a year earlier. Analysts polled by Capital IQ expected a loss of $0.13 per share.

Revenue for the quarter ended March 31 was $11.3 million, up from $8.6 million a year ago. Analysts polled by Capital IQ expected $7.4 million.

For 2024, the company said it continues to expect a flat to 5% year-over-year growth in core business revenue.

Price: 4.75, Change: +0.82, Percent Change: +20.87